COMMUNIQUÉS West-GlobeNewswire

Cronos Group Inc. Shareholders Approve C$2.4 Billion Strategic Investment from Altria Group, Inc.

21/02/2019 - 23:34

TORONTO, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) announced that at a Special Meeting held today, the Company’s shareholders overwhelmingly [...]

Alder BioPharmaceuticals® to Present at the 8th Annual SVB Leerink Global Healthcare Conference

21/02/2019 - 23:17

BOTHELL, Wash., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]

bioLytical Laboratories Earns MDSAP Certification, Highest Quality Standard in Medical Device Industry

21/02/2019 - 23:00

Audits confirm bioLytical’s Quality Management System fulfils latest standards for multiple regulatory jurisdictions including US FDA and Health Canada. RICHMOND, British Columbia, Feb. 21, 2019 (GLOBE NEWSWIRE) -- [...]

Moleculin Biotech, Inc. Reports Financial Results for the Year Ended December 31, 2018

21/02/2019 - 22:59

HOUSTON, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), a clinical-stage pharmaceutical company focused on the development of oncology drug candidates, all of [...]

Profound Medical to Release Fourth Quarter and Full Year 2018 Financial Results on March 7 – Conference Call to Follow

21/02/2019 - 22:30

TORONTO, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide a therapeutics platform that combines real-time Magnetic Resonance (“MR [...]

Flexion Therapeutics Announces New In Vitro Data Showing Protective Effects of Triamcinolone Acetonide on Cartilage

21/02/2019 - 22:30

Study conducted in collaboration with MIT showed that triamcinolone acetonide had protective effects on inflamed and/or injured cartilage in an established preclinical model Data presented in “late breaker” session at [...]

Globus Medical Reports Full Year and Fourth Quarter 2018 Results

21/02/2019 - 22:15

AUDUBON, Pa., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, today announced its financial results for the fourth quarter and year ended December 31, [...]

KemPharm to Report Fourth Quarter and Year End 2018 Results

21/02/2019 - 22:15

Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Thursday, February 28, 2019, 4:30 p.m. ET CELEBRATION, Fla., Feb. 21, 2019 (GLOBE NEWSWIRE) -- KemPharm, Inc. (Nasdaq:KMPH), a specialty [...]

Equillium to Present at Leerink Partners Global Healthcare Conference

21/02/2019 - 22:07

LA JOLLA, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a biotechnology company developing treatments for severe immune-inflammatory disorders, announced today that Bruce Steel, Equillium’s [...]

Synthorx to Present at the 8th Annual SVB Leerink Global Healthcare Conference

21/02/2019 - 22:05

SAN DIEGO, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Synthorx, Inc. (NASDAQ: THOR), a biotechnology company using a first-of-its-kind Expanded Genetic Alphabet platform technology to discover and develop optimized biologics for [...]

Calithera Biosciences Initiates Phase 1 Trial of Arginase Inhibitor CB-280 for the Treatment of Cystic Fibrosis

21/02/2019 - 22:05

SOUTH SAN FRANCISCO, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company focused on discovering and developing novel small molecule drugs for the [...]

Emergent BioSolutions Reports Fourth Quarter and Full Year 2018 Financial Results

21/02/2019 - 22:05

GAITHERSBURG, Md., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) reported financial results for the quarter and year ended December 31, 2018. FINANCIAL HIGHLIGHTS (in millions) Q4 2018 ( [...]

Opiant Pharmaceuticals Announces Top-line Results from Phase 2 Clinical Trial of OPNT001 for Treatment of Bulimia Nervosa

21/02/2019 - 22:05

-Study did not meet primary endpoint- -Company discontinuing development of OPNT001 for treatment of Bulimia Nervosa- -Focus remains on advancing lead product candidate, OPNT003, for treatment of opioid overdose, and [...]

HTG Molecular Diagnostics to Announce Fourth Quarter and Fiscal Year Ended December 31, 2018 Financial Results and Host Conference Call on Thursday, March 7

21/02/2019 - 22:05

TUCSON, Ariz., Feb. 21, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM), a life science company whose mission is to advance precision medicine, today announced that it will report its financial [...]

SI-BONE To Report Fourth Quarter and Full Year 2018 Financial Results on March 7, 2019

21/02/2019 - 22:05

SANTA CLARA, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company that is pioneering the minimally invasive surgical treatment of the sacroiliac joint with the iFuse Implant [...]

BioTelemetry, Inc. Reports Fourth Quarter 2018 Financial Results

21/02/2019 - 22:05

Delivered Best Performance in Company’s History Exceeded Expectations MALVERN, Pa., Feb. 21, 2019 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the [...]

Assertio Therapeutics to Report Fourth Quarter and Full Year 2018 Financial Results After The Close of Markets on Wednesday, March 6, 2019

21/02/2019 - 22:05

LAKE FOREST, Ill., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Assertio Therapeutics, Inc. (NASDAQ:ASRT) today announced that it will release fourth quarter and full year 2018 financial results on Wednesday, March 6, 2019, after [...]

GenMark Diagnostics Reports Fourth Quarter and Full Year 2018 Results

21/02/2019 - 22:05

CARLSBAD, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the [...]

TRACON to Report Fourth Quarter and Full Year 2018 Company Highlights and Financial Results on February 28, 2019

21/02/2019 - 22:03

SAN DIEGO, Feb. 21, 2019 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer [...]